chrX-136548847-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_016267.4(VGLL1):āc.473A>Gā(p.Glu158Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,210,548 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016267.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VGLL1 | NM_016267.4 | c.473A>G | p.Glu158Gly | missense_variant | 3/5 | ENST00000370634.8 | NP_057351.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VGLL1 | ENST00000370634.8 | c.473A>G | p.Glu158Gly | missense_variant | 3/5 | 1 | NM_016267.4 | ENSP00000359668.3 | ||
VGLL1 | ENST00000440515.5 | c.365A>G | p.Glu122Gly | missense_variant | 2/4 | 3 | ENSP00000398360.1 | |||
VGLL1 | ENST00000456412.1 | c.41-1921A>G | intron_variant | 3 | ENSP00000388868.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 14AN: 112283Hom.: 0 Cov.: 23 AF XY: 0.0000580 AC XY: 2AN XY: 34457
GnomAD3 exomes AF: 0.0000491 AC: 9AN: 183329Hom.: 0 AF XY: 0.0000295 AC XY: 2AN XY: 67813
GnomAD4 exome AF: 0.0000173 AC: 19AN: 1098265Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 4AN XY: 363619
GnomAD4 genome AF: 0.000125 AC: 14AN: 112283Hom.: 0 Cov.: 23 AF XY: 0.0000580 AC XY: 2AN XY: 34457
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The c.473A>G (p.E158G) alteration is located in exon 3 (coding exon 2) of the VGLL1 gene. This alteration results from a A to G substitution at nucleotide position 473, causing the glutamic acid (E) at amino acid position 158 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at